The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of IMGN632, a novel CD123-targeting antibody-drug conjugate, in patients with relapsed/refractory acute myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm, and other CD123-positive hematologic malignancies.
 
Naval Guastad Daver
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Immunogen; Incyte; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Nohla Therapeutics; Pfizer; Servier
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Immunogen; Incyte; Novartis; Pfizer; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Celyad; Daiichi Sankyo; Jazz Pharmaceuticals; Kite/Gilead; Kura Oncology; Macrogenics; Pfizer; PTC Therapeutics; Stemline Therapeutics
Speakers' Bureau - Jazz Pharmaceuticals; Stemline Therapeutics
 
Elisabetta Todisco
No Relationships to Disclose
 
Corrado Tarella
No Relationships to Disclose
 
Giovanni Martinelli
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Incyte; Jazz Pharmaceuticals; Pfizer; Roche
Speakers' Bureau - Jazz Pharmaceuticals; Menarini; Novartis
Research Funding - Daiichi Sankyo; Pfizer
Travel, Accommodations, Expenses - Abbvie; Daiichi Sankyo; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Pfizer
 
Harry Paul Erba
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Jazz Pharmaceuticals; Macrogenics; Novartis; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene; Incyte; Jazz Pharmaceuticals; Novartis
Research Funding - Abbvie
Other Relationship - Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo
 
Eric Deconinck
Leadership - Stemline Therapeutics
Consulting or Advisory Role - Immunogen
Research Funding - Immunogen (Inst); Novartis/Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Immunogen; Janssen-Cilag; Novartis/Pfizer; Stemline Therapeutics
 
Kendra L Sweet
Leadership - Immtech (I)
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Stemline Therapeutics; Takeda
Research Funding - Incyte (Inst)
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Agios; Amgen; argenx; Astellas Pharma; BiolineRx; BiVictriX; Boston Biomedical; Covagen; Daiichi Sankyo; Emergent Biosolutions; Janssen; Jazz Pharmaceuticals; Kite, a Gilead company; Macrogenics; Newlink Genetics; Pfizer; Race Oncology
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Agios (Inst); Amgen (Inst); Aptevo Therapeutics; Arog (Inst); BiolineRx (Inst); Celgene; Immunogen (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Pfizer; Seagen (Inst); Selvita (Inst); Stemline Therapeutics (Inst)
 
Moshe Yair Levy
No Relationships to Disclose
 
Naveen Pemmaraju
Employment - MD Anderson Cancer Center
Leadership - ASH
Honoraria - Abbvie; Blueprint Medicines; Celgene; DAVA Pharmaceuticals; Incyte; LFB Biotechnologies; MustangBio; Novartis; Pacylex; Roche Molecular Diagnostics; Stemline Therapeutics
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Celgene; Incyte; LFB Biotechnologies; MustangBio; Novartis; Pacylex; Roche Molecular Diagnostics; Stemline Therapeutics
Research Funding - Abbvie; Affymetrix/Thermo Fisher Scientific; Cellectis; Daiichi Sankyo; Novartis; Plexxikon; Samus Therapeutics; Stemline Therapeutics
Travel, Accommodations, Expenses - Abbvie; Celgene; DAVA Pharmaceuticals; mustangbio; Stemline Therapeutics
(OPTIONAL) Uncompensated Relationships - Dan's House of Hope; Oncology Times
 
Andrew A. Lane
Consulting or Advisory Role - Stemline Therapeutics
Research Funding - Abbvie; Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Methods for determining and treating toxin-conjugate resistance in cancer. (Inst)
 
David Rizzieri
Consulting or Advisory Role - Abbvie; arog; bayer; Celgene; celgene (I); celltrion; Gilead Sciences; incyte; Jazz Pharmaceuticals; Kite, a Gilead company; Millennium (I); MustangBio; novartis; onyx (I); pfizer; pharmacyclics; Sanofi; Seagen; Stemline Therapeutics; Teva
Speakers' Bureau - Celgene; Celgene (I); Gilead Sciences; incyte; Millennium (I); Seagen; Stemline Therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Ambit BioSciences (Inst); Arog (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Asuragen (Inst); Bristol-Myers Squibb (Inst); Cantex Pharmaceuticals (Inst); Celator (Inst); Eureka Therapeutics (Inst); FORMA Therapeutics (Inst); Genentech (Inst); Helsinn Healthcare (Inst); KaloBios (Inst); Macrogenics (Inst); MedImmune (Inst); MEI Pharma (Inst); Nohla Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sellas Life Sciences (Inst); Stemline Therapeutics (Inst); Syros Pharmaceuticals (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst)
Expert Testimony - Celltrion; Celltrion
Other Relationship - takeda (I)
 
Marina Konopleva
Honoraria - Abbvie; Genentech; Roche
Consulting or Advisory Role - AbbVie; Genentech/Roche
Research Funding - Abbvie (Inst); Genentech (Inst); Roche (Inst)
 
Callum Mortimer Sloss
Employment - ImmunoGen
 
Jiuzhou Wang
Employment - ImmunoGen
 
Kara E Malcolm
Employment - ImmunoGen
 
Patrick A Zweidler-McKay
Employment - Immunogen
Stock and Other Ownership Interests - Immunogen
Patents, Royalties, Other Intellectual Property - Patent applications submitted, no royalties